Isoray (NYSE:ISR) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Isoray (NYSE:ISRGet Rating) in a report issued on Friday. The brokerage issued a sell rating on the stock.

Isoray Price Performance

ISR opened at $0.35 on Friday. Isoray has a 1 year low of $0.25 and a 1 year high of $0.75. The stock has a 50-day moving average price of $0.34 and a 200-day moving average price of $0.33. The firm has a market cap of $50.00 million, a PE ratio of -7.00 and a beta of 0.92.

Isoray Company Profile

(Get Rating)

Isoray, Inc, through its subsidiary, IsoRay Medical, Inc, develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers.

Featured Stories

Receive News & Ratings for Isoray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Isoray and related companies with MarketBeat.com's FREE daily email newsletter.